PT - JOURNAL ARTICLE AU - Adiga, Aniruddha AU - Venkatramanan, Srinivasan AU - Schlitt, James AU - Peddireddy, Akhil AU - Dickerman, Allan AU - Bura, Andrei AU - Warren, Andrew AU - Klahn, Brian D AU - Mao, Chunhong AU - Xie, Dawen AU - Machi, Dustin AU - Raymond, Erin AU - Meng, Fanchao AU - Barrow, Golda AU - Mortveit, Henning AU - Chen, Jiangzhuo AU - Walke, Jim AU - Goldstein, Joshua AU - Wilson, Mandy L AU - Orr, Mark AU - Porebski, Przemyslaw AU - Telionis, Pyrros A AU - Beckman, Richard AU - Hoops, Stefan AU - Eubank, Stephen AU - Baek, Young Yun AU - Lewis, Bryan AU - Marathe, Madhav AU - Barrett, Chris TI - Evaluating the impact of international airline suspensions on the early global spread of COVID-19 AID - 10.1101/2020.02.20.20025882 DP - 2020 Jan 01 TA - medRxiv PG - 2020.02.20.20025882 4099 - http://medrxiv.org/content/early/2020/03/02/2020.02.20.20025882.short 4100 - http://medrxiv.org/content/early/2020/03/02/2020.02.20.20025882.full AB - Global airline networks play a key role in the global importation of emerging infectious diseases. Detailed information on air traffic between international airports has been demonstrated to be useful in retrospectively validating and prospectively predicting case emergence in other countries. In this paper, we use a well-established metric known as effective distance on the global air traffic data from IATA to quantify risk of emergence for different countries as a consequence of direct importation from China, and compare it against arrival times for the first 24 countries. Using this model trained on official first reports from WHO, we estimate time of arrival (ToA) for all other countries. We then incorporate data on airline suspensions to recompute the effective distance and assess the effect of such cancellations in delaying the estimated arrival time for all other countries. Finally we use the infectious disease vulnerability indices to explain some of the estimated reporting delays.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to thank members of the Network Systems Science and Advanced Computing (NSSAC) Division for interesting discussion and suggestions related to epidemic science and machine learning. This work was partially supported by National Institutes of Health (NIH) Grant 1R01GM109718, NSF BIG DATA Grant IIS-1633028, NSF DIBBS Grant ACI-1443054, DTRA subcontract/ARA S-D00189-15-TO-01-UVA, NSF Grant No.: OAC-1916805, US Centers for Disease Control and Prevention 75D30119C05935 and a collaborative seed grant from the UVA Global Infectious Disease Institute.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data except from proprietary sources used in the analysis are made available as Supplemental material. https://doi.org/10.18130/V3/Z6524P